(Q74469861)

English

Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts

scientific article published on 01 March 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

based on heuristic

inferred from title

author name string

A Middleton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

B Middleton

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1391

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

117-132

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Molecular mechanisms of diverse actions of prostanoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Effect of human native low-density and high-density lipoproteins on prostaglandin production by mouse macrophage cell line P388D1: possible implications in pathogenesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Cyclic AMP-mediated hormonal control of LDL receptor activity in cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Structural domain of apolipoprotein A-I involved in its interaction with cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Monoclonal antibodies to human apolipoprotein Al: probing the putative receptor binding domain of apolipoprotein Al

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Relationship in adipose cells between the presence of receptor sites for high density lipoproteins and the promotion of reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Decrease in high density lipoprotein binding sites is associated with decrease in intracellular cholesterol efflux in dedifferentiated aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Specific high-affinity binding of high density lipoproteins to cultured human skin fibroblasts and arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Purification of an apolipoprotein A binding protein from mouse adipose cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Characterization and purification of proteins which bind high-density lipoprotein. A putative cell-surface receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Affinity purification of the hepatic high-density lipoprotein receptor identifies two acidic glycoproteins and enables further characterization of their binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

HDL3Stimulates Multiple Signaling Pathways in Human Skin Fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Uptake of rat plasma HDL subfractions labeled with [3H]cholesteryl linoleyl ether or with 125I by cultured rat hepatocytes and adrenal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Elevation of cyclic AMP in human skin fibroblasts results in increased capacity for HDL binding

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Prostaglandins increase HDL binding to human cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

The synthesis and characterisation of 2-methylacetoacetyl coenzyme A and its use in the identification of the site of the defect in 2-methylacetoacetic and 2-methyl-3-hydroxybutyric aciduria

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

19 Receptor-mediated endocytosis of low-density lipoprotein in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

1 Assay of adenylyl cyclase catalytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

2 Cellular responsiveness to hormones and neutrotransmitters: Conversion of 3HAdenine to 3HcAMP in cell monolayers, cell suspensions, and tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Regulation of neutral cholesteryl esterase in arterial smooth muscle cells: stimulation by agonists of adenylate cyclase and cyclic AMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Hormone-sensitive lipase is responsible for the neutral cholesterol ester hydrolase activity in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Internalization and down-regulation of the prostacyclin receptor in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900207-5

7 January 2021

Identifiers

10.1016/S0005-2760(97)00207-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9554975%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74469861&oldid=2243350155"